3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
85
Lymphoma, Follicular
53
Lymphoma
50
Lymphoma, Non-Hodgkin
47
Lymphoma, Mantle-Cell
45
Lymphoma, B-Cell, Marginal Zone
45
Leukemia, Lymphocytic, Chronic, B-Cell
40
Lymphoma, B-Cell
31
Recurrence
20
Burkitt Lymphoma
20
Waldenstrom Macroglobulinemia
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Neoplasms
16
Leukemia
11
Leukemia, Hairy Cell
7
Lymphoproliferative Disorders
5
Hodgkin Disease
5
Hematologic Neoplasms
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Acute
4
Hematologic Diseases
4
Dendritic Cell Sarcoma, Interdigitating
4
Neoplasm, Residual
3
Lymphoma, AIDS-Related
3
Leukemia, Myeloid, Accelerated Phase
3
Leukemia, Biphenotypic, Acute
3
Epstein-Barr Virus Infections
3
beta-Thalassemia
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Interventions
neurotropin
1
haloperidol decanoate
1
fludarabine phosphate
1
fludarabine
1
axicabtagene ciloleucel
1
Temozolomide
1
Tadalafil
1
Surveys and Questionnaires
1
Simvastatin
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Nutritional Status
1
N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid
1
Lorazepam
1
Interleukin 1 Receptor Antagonist Protein
1
Exercise Therapy
1
Exercise
1
Dexamethasone
1
Cyclophosphamide
1
Bendamustine Hydrochloride
1
AP 1903 reagent
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neurotoxicity Syndromes
×
Rituximab
×
1 year
×
Clear all
No trials found.